Used in the treatment of moderate to severe plaque psoriasis by specifically targeting and neutralizing interleukin-23 (IL-23), a key cytokine involved in inflammatory pathways. It helps reduce skin inflammation, plaque formation, and disease progression in patients who do not respond adequately to topical therapies or other systemic treatments. Also under investigation for use in other autoimmune conditions such as psoriatic arthritis and inflammatory bowel disease due to its role in modulating immune responses. Employed as a reference standard in bioanalytical assays for the development and quality control of biosimilars and related biologics.